Speaker illustration

Professor Adnan Kastrati

German Heart Center Muenchen Technical University of Munich, Munich (Germany)

Member of:

European Society of Cardiology

Received his medical degree from the University of Tirana, Albania and completed his training in Cardiology in the University Hospital Center, Tirana, Albania. Completed fellowships in Interventional Cardiology at the University of Heidelberg and Technical University of Munich, Germany. Designed and conducted a large number of randomized clinical trials, mostly identifiable by the “ISAR”-acronym. Wrote or contributed to more than 800 original publications. His interests focus is on reperfusion strategies in acute myocardial infarction, evaluation of new device technologies in interventional cardiology, peri-interventional antithrombotic therapy and genetics in cardiovascular medicine. Received Sven-Effert-Award (2009) and the Paul Morawitz Award (2015) from the German Society of Cardiology. He is also the recipient of The ETHICA Award (2014) from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Andreas Grüntzig Award (2014) (2014) from the ESC.

Percutaneous coronary intervention and outcomes

Event: ESC Congress 2022

Topic: Percutaneous Coronary Intervention (PCI)

Session type: Moderated ePosters


Coronary complications and how to fix them

Event: ESC Congress 2021 - The Digital Experience

Topic: Interventional Cardiology

Session type: Cardiology Toolbox


Highlights from the Young in emerging cardiovascular interventions

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session type: Highlights from the Young


Atrial fibrillation in the context of acute coronary syndromes and coronary intervention: what should we do?

Event: ESC Congress 2018

Topic: Arrhythmias, General

Session type: Symposium


Meet the trialist - GLOBAL LEADERS TRIAL - A randomized comparison of 24 month ticagrelor and 1 month aspirin versus 12 month dual antiplatelet therapy followed by aspirin monotherapy

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session type: Late-Breaking Science


NSTEMI - I came, I diagnosed, I treated

Event: ESC Congress 2016

Topic: Thrombosis and platelets

Session type: Guidelines in Practice


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb